Many drugs used for the treatment of diseases present chiral properties. In this study we aimed to produce an optically pure stereoisomer that is a key intermediate for the production of steroidal medicines such as levonorgestrel or gestodene. The targeted stereoisomer was the (13R, 17S)-methyl secol, which can be produced by the asymmetric reduction of